Literature DB >> 678443

Nitroblue tetrazolium test: early gross detection of human myocardial infarcts.

N W Derias, C W Adams.   

Abstract

The hearts from 81 cases of suspected myocardial infarction were stained with the nitroblue tetrazolium (NBT) test to show damaged heart muscle in the gross at necropsy. Thirty-seven cases were of stated clinical age less than 12 h and 27 of these were less than 5 h. Seven out of 17 cases under 1 h were negative with NBT, but all other cases showed either focal diminution of staining with the dark blue diformazan or patchy red staining with the monogormazan of NBT. Thus the method may be of diagnostic value at necropsy from 1 h onwards after the time of apparent infarction (stated clinical onset). Satisfactory results were obtained up to 3 days at ambient temperature after death and for longer when the corpse was stored at 4 degrees C.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 678443      PMCID: PMC2041359     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  9 in total

1.  Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity.

Authors:  M M NACHLAS; T K SHNITKA
Journal:  Am J Pathol       Date:  1963-04       Impact factor: 4.307

2.  Myocardial infarction with and without acute coronary occlusion; a pathologic study.

Authors:  R D MILLER; H B BURCHELL; J E EDWARDS
Journal:  AMA Arch Intern Med       Date:  1951-11

3.  The ageing of cardiac infarcts, and its influence on cardiac rupture.

Authors:  I LODGE-PATCH
Journal:  Br Heart J       Date:  1951-01

4.  Postmortem delineation of infarcted myocardium. Coronary perfusion with nitro blue tetrazolium.

Authors:  S Feldman; S Glagov; R W Wissler; R H Hughes
Journal:  Arch Pathol Lab Med       Date:  1976-01       Impact factor: 5.534

5.  New histochemical method for morphologic diagnosis of early stages of myocardial ischemia.

Authors:  J T Lie; K E Holley; W R Kampa; J L Titus
Journal:  Mayo Clin Proc       Date:  1971-05       Impact factor: 7.616

6.  Early myocardial infarction. Practical methods for its post-mortem demonstration.

Authors:  B Knight
Journal:  J Forensic Med       Date:  1967 Jul-Sep

7.  Postmortem detection of inapparent myocardial infarction.

Authors:  J G McVie
Journal:  J Clin Pathol       Date:  1970-04       Impact factor: 3.411

8.  Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi.

Authors:  M J Davies; N Woolf; W B Robertson
Journal:  Br Heart J       Date:  1976-07

9.  Histopathology of early myocardial infarcts. A new approach.

Authors:  B Bouchardy; G Majno
Journal:  Am J Pathol       Date:  1974-02       Impact factor: 4.307

  9 in total
  6 in total

1.  The 'nothing dehydrogenase' reaction and the detection of ischaemic damage.

Authors:  W M Frederiks; F Marx; G L Myagkaya
Journal:  Histochem J       Date:  1989 Sep-Oct

2.  Limitations of tetrazolium salts in delineating infarcted brain.

Authors:  T M Liszczak; E T Hedley-Whyte; J F Adams; D H Han; V S Kolluri; F X Vacanti; R C Heros; N T Zervas
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

3.  Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats.

Authors:  M T Vivaldi; R A Kloner; F J Schoen
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

4.  Macroscopic enzyme histochemistry in myocardial infarction: use of coenzyme, cyanide, and phenazine methosulphate.

Authors:  N W Derias; C W Adams
Journal:  J Clin Pathol       Date:  1982-04       Impact factor: 3.411

5.  Macroscopic enzyme histochemistry in myocardial infarction: artefactual nature of the creatine phosphokinase reaction.

Authors:  N W Derias; C W Adams
Journal:  J Clin Pathol       Date:  1982-04       Impact factor: 3.411

6.  The application of selected histochemical and immunohistochemical markers and procedures to the diagnosis of early myocardial damage.

Authors:  B Brinkmann; M A Sepulchre; G Fechner
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.